Join us on Nov 17th 1pm ET/10am PT for Democratizing Lung Functional Genomics with AI, presented by Nathan Salomonis @nsalomonis from @CincyChildrens! Register @ https://t.co/evdO42yEdI @ATS_Assemblies @ATS_AII @ATS_RCMB @ATS_RSF

How to develop good research questions https://t.co/XIjlYux0hC #MedEd #MedX #Science #phdlife #PHD #AcademicTwitter #academicWriting

Predicting protein-protein interactions in the human proteome Predicting which human proteins shake hands—and how—is a longstanding bottleneck. Proteins rarely act alone; they assemble into complexes that drive immunity, metabolism, signaling, and disease. But testing hundreds

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A 192-Week, Phase 3, Open-Label Extension Study @atscommunity 🔗 https://t.co/B80KCZUvtT

1/ Finally! Our call on the U.S. medical community & establishment to break their silence on Gaza is out today at the New England Journal of Medicine. This is the first publication describing Gaza's human made humanitarian catastrophe in the Journal!! https://t.co/jMn4sydlEw

Tune in for an interactive “Ask the Expert” session on bronchiectasis at 3 p.m. ET on Oct. 27, 2025, with Anne O’Donnell, MD, Georgetown University Hospital. Explore how to recognize and diagnose the disease, understand the impact of exacerbations on progression and review

New Article! Selecting aminoacyl-tRNA synthetase/tRNA pairs for efficient genetic encoding of noncanonical amino acids into proteins https://t.co/kUK4SbXqwJ

📆 Save the date! Join @FIRS_LungsFirst for a special World Lung Day webinar redefining lung health at 8 a.m. ET. on Thursday, Sept. 25. It will feature the new FIRS Lung Health Taskforce discussing tools to improve how lung conditions are diagnosed and managed—especially in

📣Call for Papers! 📣 Looking for articles highlighting the spectrum of discovery in thoracic malignancies 📅Deadline: October 28, 2025 🔬Learn More Here: https://t.co/2GbPVXV5ul 🖱️Submit here: https://t.co/WBtyzclsPJ @atscommunity @atstoa

Could decentralized clinical trials be the way forward? Reynold Panettieri, MD, from Rutgers University, thinks it presents key opportunities for both researchers and patients. Hear him describe his work on the BATURA trial, an at-home trial for those with moderate-to-severe

Trial Analysis and Interpretation in Critical Care Using the Evidential (Likelihood) Approach: Rationale and Practical Considerations The Evidential approach bridges frequentist & Bayesian methods in critical care trials @Michael_Harhay @f_g_zampieri 🔗 https://t.co/a7EVVxlMdt

Racial & Ethnic and Sex Differences in At-Home Estimates of OSP Parameters among Diverse Adults Wake up to sleep disparities: Black adults may have more respiratory events during REM sleep than white adults @YueLengsleep @clem_cavailles @KristineYaffe https://t.co/qerMAGIPXn

A new @SciSignal study reveals how a cytokine cocktail used to activate natural killer cells for cancer #immunotherapy invigorates their antitumor abilities through a twin-pronged molecular pathway, potentially informing future clinical applications. https://t.co/S1uuV2JdIf

𝐒𝐢𝐧𝐠𝐥𝐞-𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞 𝐩𝐨𝐥𝐲𝐦𝐨𝐫𝐩𝐡𝐢𝐬𝐦 (𝐒𝐍𝐏) is a type of variation affecting a single nucleotide in a DNA sequence, in which the nucleotide (for example, cytosine) is substituted with a different type of nucleotide (for example, thymidine). To learn more

I recently learned that the novelist, Cormac McCarthy, spent several years at the Santa Fe Institute helping scientists write papers. His advice was condensed into a brief Nature column. The first three points, and some of the final points, are really good. (h/t @eryney_ok)

Phasing millions of samples achieves near perfect accuracy, enabling parent-of-origin analyses @amythewilliams and colleagues @GeneticsSociety members' research highlight from @HGGAdvances https://t.co/xRWRPPw5oq

In #bronchiectasis, neutrophil serine proteases present as promising, treatment-responsive biomarkers in the disease, summarized in this beautiful paper @ERSpublications https://t.co/eqrCLmzyhB

The 2026 ATS New Faculty Boot Camp will have tailored sessions for the Basic (PhD) Scientist track. Also, for the first time, non-U.S./Canadian residents can apply for admittance to the 2026 Basic (PhD) Scientist track! Registration details coming soon for 2026!

Really cool: "Sex-biased Gene Expression Underlies Immune Dysfunction in Asthma " Kudos Drs Kay and Gomez and team!!! #DemistifyAsthma https://t.co/4RMjYMrcaV

scRNA-seq reveals that VEGF signaling mediates the response to neoadjuvant anlotinib combined with PD-1 blockade therapy in non-small cell lung cancer